Successful treatment of candida albicans septicemia in a preterm infant with severe congenital ichthyosis (Harlequin baby)

Pediatric Dermatology

Volumn 26, Issue 5, 2009, Pages 575-578

  Haase, Roland ^a   Kreft, Burkhard ^a   Foell, Jürgen ^a   Kekulé, Alexander S ^a   Merkel, Nick ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; BRILLIANT GREEN; CASPOFUNGIN; CEFOTIAM; ETRETIN; FLUCONAZOLE; FUSIDIC ACID; MEROPENEM; VANCOMYCIN;

ARTICLE; CANDIDA ALBICANS; CASE REPORT; DEHYDRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; FEMALE; HUMAN; ICHTHYOSIS; INVASIVE CANDIDIASIS; NEWBORN; NEWBORN PERIOD; PREMATURITY; PRIORITY JOURNAL; SEPSIS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDIASIS; DRUG THERAPY, COMBINATION; ECHINOCANDINS; FEMALE; HUMANS; ICHTHYOSIS, LAMELLAR; INFANT, NEWBORN; INFANT, PREMATURE; SEPSIS;

EID: 70350028230     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2009.00989.x     Document Type: Article

References (14)

1. Leibovitz E. Neonatal candidosis: clinical picture, management controversies and consensus, and new therapeutic options. J Antimicrob Chemother 2002 49 : 69 73.
2. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998 17 : 504 508.
3. Odio CM, Araya R, Pinto LE et al. Caspofungin therapy of neonates with invasive candidiasis. Pediatr Infect Dis J 2004 23 : 1093 1097.
4. Layton J. A review of harlequin ichthyosis. Neonatal Netw 2005 24 : 17 23.
5. Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol 2003 49 : 171 182.
6. Shwayder T, Akland T. Neonatal skin barrier: structure, function and disorders. Dematol Ther 2005 18 : 87 103.
7. Parikh TB, Nanavati RN, Patankar CV et al. Fluconazole Prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants. Indian Pediatr 2007 44 : 830 837.
8. Freij BJ, McCracken GH. Acute infections. In : Avery GB, Fletcher MA, McDonald MG, eds. Neonatology. Philadelphia : Lippincott Williams & Wilkins, 1999 : 1189 1230.
9. Wertz KK, Pretzlaff RK. Caspofungin in a pediatric patient with persistent candidemia. Pediatr Crit Care Med 2004 5 : 181 183.
10. Natarajan G, Lulic-Botica M, Rongkavilit C et al. Experience with caspofungin in the treatment of persistent fungemia in neonates. J Perinatol 2005 25 : 770 777.
11. Manzar S, Kamat M, Pyati S. Caspofungin for refractory candidemia in neonates. Pediatr Infect Dis J 2006 25 : 282 283.
12. Belet N, Ciftçi E, Ince E et al. Caspofungin treatment in two infants with persistent fungaemia due to Candida lipolytica. Scand J Infect Dis 2006 387 : 559 562.
13. Johnson MD, MacDougall C, Ostrosky-Zeichner L et al. Combination antifungal therapy. Antimicrob Agents Chemother 2004 48 : 693 715.
14. Hossain MA, Reyes GH, Long LA et al. Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans. J Antimicrob Chemother 2003 51 : 1427 1429.